Keros Therapeutics, Inc.KROSNASDAQ
Loading
Total Costs & Expenses Over TimeContracting
Percentile Rank86
3Y CAGR+15.4%
5Y CAGR+30.5%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
+15.4%/yr
vs +78.4%/yr prior
5Y CAGR
+30.5%/yr
Recent deceleration
Acceleration
-63.0pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
3.8x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$176.49M-17.7%
2024$214.38M+26.0%
2023$170.09M+48.2%
2022$114.79M+50.1%
2021$76.47M+63.9%
2020$46.66M+133.2%
2019$20.00M+76.7%
2018$11.32M-